Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Eric Honroth

Eric Honroth is recorded as CEO and Board Member at Angiodynamics Inc (ANGO). Angiodynamics Inc reported in an 8-K filed October 8, 2026 that Eric Honroth was appointed director, effective November 2, 2026. Angiodynamics Inc reported in an 8-K filed October 8, 2026 that Eric Honroth was appointed President and Chief Executive Officer, effective November 2, 2026.

“In addition, Mr. Honroth was appointed as a director on the Company’s Board as of the Effective Date, conditioned upon his commencement of service as President and Chief Executive Officer and concurrently with Mr. Clemmer’s retirement from his position as a member of the Board.”
Angiodynamics Inc Form 8-K, filed October 8, 2026 · Read the filing
“On October 2, 2026, the Board of Directors of the Company (the “Board”) appointed Eric Honroth to serve as President and Chief Executive Officer of the Company, effective as of November 2, 2026 (the “Effective Date”) and concurrently with Mr. Clemmer’s retirement.”
Angiodynamics Inc Form 8-K, filed October 8, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Angiodynamics Inc

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.